Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 9/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ITPR3 | Q14573 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.43 |
| ▸ | MMP14 | P50281 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorescein SCHEMBL5409874 | 0.88 | FTO (0.58) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL5411973 | 0.87 | FTO (0.58) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL3426429 | 0.86 | FTO (0.59) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL6244972 | 0.80 | FTO (0.69) | FTOMAPTMEN1HTTKMT2A | |
| Fluorescein SCHEMBL8373796 | 0.80 | FTO (0.47) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL4736276 | 0.79 | FTO (0.47) | FTOMAPTMEN1HTTKMT2A | |
| Phosphoric Acid SCHEMBL3407741 | 0.79 | MAPT (0.57) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL723679 | 0.78 | FTO (0.58) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL5409831 | 0.77 | FTO (0.59) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL726955 | 0.76 | FTO (0.57) | FTOMAPTMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070087377-A1 | Methods and compositions for reverse translation | MIRARI BIOSCIENCES, INC. (US) | 2007-04-19 | — | — | US | disclosed |
| US-7169894-B2 | Methods and compositions for reverse translation | MIRARI BIOSCIENCES, INC. (US) | 2007-01-30 | — | — | US | disclosed |
| US-20030100000-A1 | Methods and compositions for reverse translation | MIRARI BIOSCIENCES, INC. | 2003-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100000-A1 | Methods and compositions for reverse translation | RNGTT, CPSF1, RNMT | FTO 3243/4885MAPT 3410/4885MEN1 2782/4885 |
| US-20070087377-A1 | Methods and compositions for reverse translation | RNGTT, CPSF1, RNMT | FTO 3243/4885MAPT 3410/4885MEN1 2782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.